Ajinomoto Bio-Pharma Services
Platform Technologies


About Ajinomoto
Bio-Pharma Services

Ajinomoto Bio-Pharma Services is a global CDMO (Contract Development and Manufacturing Organization) that provides comprehensive services from process development to GMP manufacturing of pharmaceutical ingredients and intermediates for small, medium and large molecules, as well as gene therapy, as a one-stop service with bases in Belgium, India, the US and Japan.

We offer a wide range of services from pre-clinical to commercial manufacturing to meet your needs. These services are based on our innovative proprietary platform technologies such as AJIPHASE® (Liquid phase production for oligonucleotide and peptide), CORYNEX® (Microbial secretory production system for small protein/peptide), and AJICAP® (site-specific conjugation and linker technology for ADC and new drug-conjugate).


Latest news


Our Platform Technologies and CDMO Capabilities

Can slide left and right

CONTINUOUS FLOW CHEMISTRY AJIPHASE

Our Platform Technologies

Ajinomoto and Ajinomoto Bio-Pharma Services offers a broad range of innovative platform technologies from pre-clinical and pilot programs to commercial quantities.

Our CDMO Capabilities

Ajinomoto Bio-Pharma Services provides comprehensive services from process development to GMP manufacturing of pharmaceutical ingredients and intermediates for small, medium and large molecules, as well as gene therapy, as a one-stop service with bases in Belgium, India, the US and Japan.


Contact Us

For further information, please contact us using the link below and an Ajinomoto Bio-Pharma Services representative will contact you.